The Jak-Stat community in Vienna forms a strong research focus, which has developed over the last decade under the mentorship and guidance of several consortium members. It is driven by local expertise generating critical mass, coinciding with increasing attention this signalling pathway has received in health and disease. Therefore the SFB-F61 is embedded into a lively research network and shares strong links and interdependencies, which are exploited for mutual benefit of the wider research community.
PHD-PROGRAM INFLAMMATION AND IMMUNITY (IAI)
of the Medical University of Vienna in collaboration with Vetmeduni Vienna funded by the Austrian Science Fund FWF
SPECIAL RESEARCH PROGRAM (SFB F47) MYELOPROLIFERATIVE NEOPLASIA
SFB-F47 is funded by the Austrian Science Fund (FWF) and comprises more than 40 scientists from 6 research institutions working together on the common goal to identify and characterize novel clinically relevant markers and targets, thereby providing novel strategies for improvement of diagnosis and therapy of patients suffering from myeloproliferative neoplasms.
EARLY DETERMINANTS OF DNA-VIRUS LYTIC OR LATENT INFECTION (EDEVILLI)
Collaborating with colleagues from Julius-Maximilians-Universität Würzburg, Karolinska Institute in Sweden, University of Veterinary Medicine in Vienna and Université de Bordeaux in France, Cicin-Sain aims to discover the details of the transition into the latency stage. Applying methods from systems biology and genetic manipulations of viruses and host cells, the researchers aim to find out under which circumstances a virus causes an immediate infection or transitions into a latency stage. EDEVILLI is funded through the second Infect-ERA joint translational call and coordinated by the Helmholtz Center for Infection Research.
